Your browser is no longer supported. Please, upgrade your browser.
Settings
EYES Second Sight Medical Products, Inc. daily Stock Chart
EYES [NASD]
Second Sight Medical Products, Inc.
Index- P/E- EPS (ttm)-0.54 Insider Own0.20% Shs Outstand65.94M Perf Week-13.75%
Market Cap60.29M Forward P/E- EPS next Y-0.44 Insider Trans- Shs Float39.13M Perf Month-37.38%
Income-33.60M PEG- EPS next Q-0.11 Inst Own10.40% Short Float9.77% Perf Quarter-47.15%
Sales8.20M P/S7.35 EPS this Y37.20% Inst Trans1.66% Short Ratio8.98 Perf Half Y-49.49%
Book/sh0.06 P/B15.24 EPS next Y15.40% ROA-269.50% Target Price5.00 Perf Year-58.06%
Cash/sh0.08 P/C12.06 EPS next 5Y- ROE-616.00% 52W Range0.82 - 2.58 Perf YTD-52.13%
Dividend- P/FCF- EPS past 5Y-2.30% ROI-362.10% 52W High-64.56% Beta2.81
Dividend %- Quick Ratio0.90 Sales past 5Y42.30% Gross Margin37.50% 52W Low11.72% ATR0.11
Employees112 Current Ratio1.40 Sales Q/Q37.50% Oper. Margin- RSI (14)29.02 Volatility14.05% 10.61%
OptionableYes Debt/Eq0.00 EPS Q/Q-4.80% Profit Margin- Rel Volume2.27 Prev Close0.86
ShortableYes LT Debt/Eq0.00 EarningsNov 07 AMC Payout- Avg Volume425.71K Price0.91
Recom2.00 SMA20-16.55% SMA50-35.28% SMA200-45.48% Volume966,953 Change6.31%
Jul-06-15Initiated H.C. Wainwright Buy $21
Dec-14-18 08:00AM  Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors GlobeNewswire +6.31%
Dec-04-18 06:18AM  Second Sight Medical Products Sees Hammer Chart Pattern: Time to Buy? Zacks -5.09%
Dec-03-18 08:17PM  Edited Transcript of EYES earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-27-18 04:30PM  Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th GlobeNewswire
Nov-12-18 08:15AM  Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire -5.84%
Nov-07-18 07:10PM  Second Sight Medical Products (EYES) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:06PM  Second Sight Medical Products: 3Q Earnings Snapshot Associated Press
04:01PM  Second Sight Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-06-18 04:01PM  Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System GlobeNewswire
Oct-30-18 08:00AM  Second Sight to Discuss Third Quarter 2018 Financial Results on November 7, 2018 Conference Call Business Wire
Oct-22-18 09:00AM  Second Sight Completes $4 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors Business Wire
Oct-18-18 08:30AM  New Research Coverage Highlights QuinStreet, Senseonics, Ring Energy, Blue Apron, Second Sight Medical Products, and Real Goods Solar Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Sep-18-18 08:00AM  Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development Business Wire
Sep-04-18 08:00AM  Second Sight Appoints Pat Ryan Chief Operating Officer Business Wire
Aug-27-18 07:40AM  Analysis: Positioning to Benefit within C&J Energy Services, LivePerson, Kadmon, Cara Therapeutics, CorMedix, and Second Sight Medical Products Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-22-18 08:00AM  Second Sight to Present at Investor Conferences in September Business Wire
Aug-16-18 08:26AM  Second Sight Medical Products (EYES): Moving Average Crossover Alert Zacks
08:00AM  Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors Business Wire
03:35AM  Edited Transcript of EYES earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-18 04:53PM  Second Sight Medical Products: 2Q Earnings Snapshot Associated Press
04:05PM  Second Sight Reports Second Quarter 2018 Financial Results Business Wire
02:30PM  Second Sight Medical Products, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-18 08:00AM  Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call Business Wire
Jun-27-18 10:53AM  Second Sight Medical Products Incs (NASDAQ:EYES) Shift From Loss To Profit Simply Wall St.
Jun-21-18 08:25AM  Analysis: Positioning to Benefit within Second Sight Medical Products, ICF International, Morningstar, Spark Therapeutics, Natera, and Kadmon Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-23-18 07:15AM  Complimentary Technical Snapshots on Prestige Brands and Three More Medical Equipment Stocks ACCESSWIRE
May-14-18 08:00AM  Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference Business Wire
May-10-18 04:48PM  Second Sight Medical Products: 1Q Earnings Snapshot Associated Press -5.39%
04:01PM  Second Sight Reports First Quarter 2018 Financial Results Business Wire
May-07-18 08:00AM  Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors Business Wire -7.27%
May-03-18 05:00PM  Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call Business Wire
May-01-18 08:10AM  Research Report Identifies Flexsteel Industries, Second Sight Medical Products, XG Technology, CRA International, Inc, Neos Therapeutics, and Tech Data with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-09-18 04:30PM  Second Sight Announces Dr. Robert Greenbergs Resignation from Board of Directors and as an Officer of the Company Business Wire
Mar-22-18 08:00AM  Second Sight Appoints John T. Blake Chief Financial Officer Business Wire
Mar-19-18 07:30AM  Research Report Identifies Anthera Pharmaceuticals, Hancock Holding, MKS Instruments, Second Sight Medical Products, Eclipse Resources, and Aircastle with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-16-18 08:00AM  Second Sight Appoints Gregg Williams as Chairman of the Board of Directors Business Wire
Mar-08-18 04:30PM  Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium Business Wire -6.49%
Mar-07-18 05:47PM  Second Sight Medical Products posts 4Q loss Associated Press
04:05PM  Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
12:30PM  Second Sight Medical Products, Inc. to Host Earnings Call ACCESSWIRE
Mar-06-18 08:00AM  Second Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis System Business Wire
Mar-05-18 08:00AM  Second Sight Medical Products, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 7, 2018 Business Wire +9.04%
Feb-28-18 08:00AM  Second Sight to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 7, 2018 Conference Call Business Wire
Feb-16-18 08:00AM  Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System Business Wire
Feb-07-18 08:00AM  Second Sight Medical, Investors Open Their Eyes Making These Shares Soar, Recent Developments ACCESSWIRE
Feb-06-18 09:21AM  Second Sight Medical Products Inc Execution Is Firing on All Cylinders Following Standout 4Q:17 Implants SmarterAnalyst -13.42%
08:55AM  Second Sight (EYES) Catches Eye: Stock Jumps 12.7% Zacks
Feb-05-18 08:00AM  Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical Implant Business Wire +12.68%
Feb-01-18 11:02AM  High Growth Stocks To Invest In Simply Wall St.
Jan-09-18 08:30AM  Investor Expectations to Drive Momentum within Cutera, Matrix Service, PRA Group, Materion, Second Sight Medical Products, and Syndax Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire
Dec-31-17 11:02AM  January Growth Opportunities Athenex And More Simply Wall St.
Dec-12-17 01:11PM  ETFs with exposure to Second Sight Medical Products, Inc. : December 12, 2017 Capital Cube +17.50%
Dec-07-17 08:48AM  Second Sight Medical (EYES) in Focus: Stock Moves 12.1% Higher Zacks
Dec-05-17 09:00AM  Second Sight Announces Market Entry into Iran with First Two Implants of Argus II Retinal Prosthesis System Business Wire
Nov-30-17 01:48PM  ETFs with exposure to Second Sight Medical Products, Inc. : November 30, 2017 Capital Cube -6.82%
Nov-20-17 12:25PM  ETFs with exposure to Second Sight Medical Products, Inc. : November 20, 2017 Capital Cube
Nov-10-17 12:22PM  ETFs with exposure to Second Sight Medical Products, Inc. : November 10, 2017 Capital Cube
08:00AM  Ontario Health Technology Advisory Committee Recommends Public Funding for Second Sights Argus II Retinal Prosthesis System Business Wire
Nov-09-17 09:03AM  Second Sight Medical Products, Inc. :EYES-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017 Capital Cube
Nov-08-17 08:00AM  Second Sight Receives FDA Expedited Access Pathway Designation for the Orion Cortical Visual Prosthesis System Business Wire
Nov-02-17 05:19PM  Second Sight Medical Products posts 3Q loss Associated Press +7.41%
04:00PM  Second Sight Reports Third Quarter 2017 Financial Results Business Wire
08:05AM  Second Sight Receives Full FDA Approval to Begin First Orion Human Clinical Study Business Wire
08:00AM  Second Sight Announces Final Medicare Hospital Outpatient Payment Rate for 2018 for the Argus II Retinal Prosthesis System Business Wire
Oct-26-17 08:00AM  Second Sight to Discuss Third Quarter 2017 Financial Results on November 2, 2017 Conference Call Business Wire
Oct-24-17 09:38AM  ETFs with exposure to Second Sight Medical Products, Inc. : October 24, 2017 Capital Cube
Oct-19-17 07:00AM  Second Sight Announces Appointments of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific; Gregoire Cosendai as Vice President, Clinical Affairs Business Wire
Oct-17-17 10:00AM  Second Sight Medical Products Inc (EYES) to Initiate Study of Argus II in Better-Sighted Retinitis Pigmentosa Patients; Shares Rose 5% SmarterAnalyst
07:00AM  Second Sight Receives Approval from Bundesinstitut für Arzneimittel und Medizinprodukte in Germany to Begin Study to Implant and Evaluate Argus II in Better-Sighted Retinitis Pigmentosa Patients Business Wire
Oct-13-17 10:46AM  ETFs with exposure to Second Sight Medical Products, Inc. : October 13, 2017 Capital Cube
Oct-02-17 10:50AM  ETFs with exposure to Second Sight Medical Products, Inc. : October 2, 2017 Capital Cube
Sep-29-17 09:03AM  Second Sight Medical Products, Inc. :EYES-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-05-17 08:00AM  Second Sight to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York on September 12th Business Wire
Aug-28-17 08:00AM  Second Sight Receives Conditional FDA Approval to Begin First Orion Human Clinical Study Business Wire +8.00%
Aug-01-17 09:57PM  Second Sight Medical Products posts 2Q loss Associated Press
04:01PM  Second Sight Reports Second Quarter 2017 Financial Results Business Wire
11:00AM  Investor Network: Second Sight Medical Products, Inc. to Host Earnings Call ACCESSWIRE
Jul-26-17 08:30AM  Second Sight Announces Market Entry into Russia with First Implant of Argus II Retinal Prosthesis System Business Wire
Jul-20-17 04:30PM  Second Sight to Discuss Second Quarter 2017 Financial Results on August 1, 2017 Conference Call Business Wire
Jul-05-17 08:00AM  Second Sight Announces Market Entry into South Korea with Two Implants and Performs Second Implant in Taiwan of Argus II Retinal Prosthesis System Business Wire
Jul-03-17 08:00AM  Second Sight Announces Expansion of Medicare Coverage for Argus II Retinal Prosthesis System to 11 Additional States and the District of Columbia Business Wire
Jun-28-17 02:48PM  ETFs with exposure to Second Sight Medical Products, Inc. : June 28, 2017 Capital Cube
Jun-16-17 03:45PM  ETFs with exposure to Second Sight Medical Products, Inc. : June 16, 2017 Capital Cube
May-26-17 01:07PM  ETFs with exposure to Second Sight Medical Products, Inc. : May 26, 2017 Capital Cube
May-17-17 08:00AM  Second Sight to Present at 18th Annual B. Riley & Co. Institutional Investor Conference Business Wire
May-15-17 03:42PM  ETFs with exposure to Second Sight Medical Products, Inc. : May 15, 2017 Capital Cube
May-12-17 11:40AM  Second Sight Medical Products, Inc. :EYES-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube
May-03-17 05:24PM  Second Sight Medical Products posts 1Q loss Associated Press
04:01PM  Second Sight Reports First Quarter 2017 Financial Results Business Wire
Apr-25-17 08:00AM  Second Sight to Discuss First Quarter 2017 Financial Results on May 3, 2017 Conference Call Business Wire
Apr-19-17 02:19PM  ETFs with exposure to Second Sight Medical Products, Inc. : April 19, 2017 Capital Cube
Apr-13-17 07:00AM  Second Sights Argus II Retinal Prosthesis Implanted in First Patient in Asia Business Wire +8.62%
Apr-07-17 04:30PM  ETFs with exposure to Second Sight Medical Products, Inc. : April 7, 2017 Capital Cube
Apr-06-17 09:07AM  Second Sight Announces Dr. Robert Greenberg, Chairman, Inducted as a National Academy of Inventors Fellow Business Wire
Mar-27-17 04:32PM  Second Sight Medical Products, Inc. Announces Warrants Approved for Listing on Nasdaq With Trading Scheduled to Commence March 29 under Symbol EYESW Business Wire
03:56PM  ETFs with exposure to Second Sight Medical Products, Inc. : March 27, 2017 Capital Cube
Mar-21-17 01:04PM  SECOND SIGHT MEDICAL PRODUCTS INC Financials
11:31AM  Second Sight Medical Products, Inc. :EYES-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Capital Cube
09:55AM  Second Sight Medical Products, Inc. :EYES-US: Earnings Analysis: 2016 By the Numbers : March 21, 2017
Mar-16-17 06:10AM  SECOND SIGHT MEDICAL PRODUCTS INC Files SEC form 10-K, Annual Report
Second Sight Medical Products, Inc., together with its subsidiaries, develops, manufactures, and markets prosthetic devices to restore functional vision of blind individuals in the United States, Canada, Europe, the Middle East, and Asia. It offers Argus II System, which treats outer retinal degenerations, such as retinitis pigmentosa. The company was formerly known as Second Sight LLC. and changed its name to Second Sight Medical Products, Inc. Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Sylmar, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williams GreggDirectorDec 12Buy0.923,275,1002,999,99236,255,772Dec 14 08:27 AM
Randolph Edward DavidVice President - ManufacturingDec 03Sale1.033,7333,84122Dec 04 08:31 AM
OKLAND STEPHEN DChief Commercial OfficerDec 03Sale1.037,7647,98923,641Dec 04 08:30 AM
McGuire Jonathan WillChief Executive OfficerNov 21Sale1.163,9204,547103,753Nov 21 08:44 PM
McGuire Jonathan WillChief Executive OfficerNov 20Option Exercise0.0011,8750107,673Nov 21 08:44 PM
Williams GreggDirectorOct 18Buy1.622,467,7673,997,78332,980,672Oct 22 07:49 PM
Williams GreggDirectorOct 16Buy1.689,98816,82030,512,945Oct 16 06:47 PM
Williams GreggDirectorOct 15Buy1.637,64512,43830,502,957Oct 16 06:47 PM
Williams GreggDirectorOct 12Buy1.627,69412,44930,495,312Oct 12 09:33 PM
Williams GreggDirectorOct 11Buy1.6011,70918,74630,487,618Oct 12 09:33 PM
Williams GreggDirectorOct 10Buy1.6015,87525,43230,475,909Oct 10 08:05 PM
Williams GreggDirectorOct 09Buy1.6410,45817,18230,460,034Oct 10 08:05 PM
Williams GreggDirectorOct 05Buy1.7215,87527,30530,449,576Oct 09 09:30 AM
Williams GreggDirectorOct 04Buy1.7910,89419,44630,433,701Oct 09 09:30 AM
Williams GreggDirectorOct 03Buy1.768,20014,39130,422,807Oct 04 06:09 PM
Williams GreggDirectorOct 02Buy1.8115,87528,75030,414,607Oct 04 06:09 PM
Williams GreggDirectorOct 01Buy1.8615,87529,54330,398,732Oct 01 08:56 PM
Williams GreggDirectorSep 28Buy1.909,22317,54230,382,857Oct 01 08:56 PM
Williams GreggDirectorSep 27Buy1.9315,87530,70230,373,634Sep 27 08:17 PM
Williams GreggDirectorSep 26Buy1.9610,87821,28830,357,759Sep 27 08:17 PM
Williams GreggDirectorSep 25Buy1.8915,87529,92430,346,881Sep 25 06:52 PM
Williams GreggDirectorSep 24Buy1.8615,52028,88330,331,006Sep 25 06:52 PM
Williams GreggDirectorSep 21Buy1.8015,87528,49630,315,486Sep 21 09:28 PM
Williams GreggDirectorSep 20Buy1.8215,87528,90830,299,611Sep 21 09:28 PM
Williams GreggDirectorSep 19Buy1.7613,74124,17030,283,736Sep 19 08:24 PM
Williams GreggDirectorSep 18Buy1.8715,87529,73430,269,995Sep 19 08:24 PM
Williams GreggDirectorSep 17Buy1.7915,87528,41630,254,120Sep 17 08:25 PM
Williams GreggDirectorSep 14Buy1.6910,20017,21830,238,245Sep 17 08:25 PM
Williams GreggDirectorSep 13Buy1.6715,87526,54330,228,045Sep 13 07:26 PM
Williams GreggDirectorSep 12Buy1.6215,87525,76530,212,170Sep 13 07:26 PM
Williams GreggDirectorSep 11Buy1.6815,87526,62230,196,295Sep 12 01:23 PM
Williams GreggDirectorSep 10Buy1.6910,60817,91730,180,420Sep 12 01:23 PM
Williams GreggDirectorSep 07Buy1.7315,87527,44830,169,812Sep 10 06:03 AM
Williams GreggDirectorSep 06Buy1.7615,87527,92430,153,937Sep 10 06:03 AM
Williams GreggDirectorSep 05Buy1.7014,95325,40530,138,062Sep 05 07:57 PM
Williams GreggDirectorSep 04Buy1.6815,87526,63830,123,109Sep 05 07:57 PM
Williams GreggDirectorAug 31Buy1.7315,87527,48030,107,234Aug 31 08:32 PM
Williams GreggDirectorAug 30Buy1.7115,87527,19430,091,359Aug 31 08:32 PM
Williams GreggDirectorAug 29Buy1.6115,72025,37230,075,484Aug 29 09:36 PM
Williams GreggDirectorAug 28Buy1.5914,14022,42630,059,764Aug 29 09:36 PM
Williams GreggDirectorAug 27Buy1.5710,62316,72130,045,624Aug 27 09:43 PM
Williams GreggDirectorAug 24Buy1.5912,70020,24430,035,001Aug 27 09:43 PM
Williams GreggDirectorAug 23Buy1.625,9839,70430,022,301Aug 23 07:51 PM
Williams GreggDirectorAug 22Buy1.6311,06918,08730,016,318Aug 23 07:51 PM
Williams GreggDirectorAug 21Buy1.6315,87525,84530,005,249Aug 21 07:24 PM
McGuire Jonathan WillChief Executive OfficerAug 20Option Exercise0.0011,8750119,575Aug 22 03:24 PM
Williams GreggDirectorAug 20Buy1.574,1106,46929,989,374Aug 21 07:24 PM
Williams GreggDirectorAug 17Buy1.567,80012,13729,985,264Aug 17 08:28 PM
Williams GreggDirectorAug 16Buy1.5610,26316,01029,977,464Aug 17 08:28 PM
Williams GreggDirectorAug 15Buy1.5315,87524,28929,967,201Aug 16 05:43 PM
Williams GreggDirectorAug 14Buy1.553,231,4875,008,86729,951,326Aug 16 05:43 PM
Williams GreggDirectorAug 13Buy1.607,00011,16526,719,839Aug 13 09:25 PM
Williams GreggDirectorAug 10Buy1.5515,87524,62226,712,839Aug 13 09:25 PM
Williams GreggDirectorAug 09Buy1.546,63410,24326,696,964Aug 09 06:23 PM
Williams GreggDirectorAug 08Buy1.5815,87525,11426,690,330Aug 09 06:23 PM
Williams GreggDirectorAug 07Buy1.677,96013,32526,674,455Aug 07 06:31 PM
Williams GreggDirectorAug 06Buy1.668,18813,56826,666,495Aug 07 06:31 PM
Williams GreggDirectorJul 27Buy1.6015,87525,43226,658,307Jul 30 08:18 PM
Williams GreggDirectorJul 26Buy1.657,87413,01626,642,432Jul 30 08:18 PM
Williams GreggDirectorJul 25Buy1.6010,40216,68526,635,638Jul 25 08:41 PM
Williams GreggDirectorJul 24Buy1.6215,87525,71826,625,236Jul 25 08:41 PM
Williams GreggDirectorJul 23Buy1.6715,87526,44826,609,361Jul 24 06:58 PM
Williams GreggDirectorJul 20Buy1.678,60114,38926,593,486Jul 24 06:58 PM
Williams GreggDirectorJul 19Buy1.696,88511,66326,584,885Jul 19 07:43 PM
Williams GreggDirectorJul 18Buy1.7215,87527,35326,578,000Jul 19 07:43 PM
Williams GreggDirectorJul 17Buy1.8015,87528,51226,562,125Jul 18 09:50 PM
Williams GreggDirectorJul 16Buy1.779,70017,12126,546,250Jul 18 09:50 PM
Williams GreggDirectorJun 15Buy1.809,32716,79826,536,550Jun 18 06:03 AM
Williams GreggDirectorJun 14Buy1.8224,49844,46426,527,223Jun 14 09:40 PM
Williams GreggDirectorJun 13Buy1.8610,73719,93926,502,725Jun 14 09:40 PM
Williams GreggDirectorJun 12Buy1.8321,73739,82226,491,988Jun 12 08:45 PM
Williams GreggDirectorJun 11Buy1.8426,92249,51026,470,251Jun 12 08:45 PM
Williams GreggDirectorJun 08Buy1.8016,95430,48326,443,329Jun 08 09:45 PM
Williams GreggDirectorJun 07Buy1.8629,90855,56926,426,375Jun 08 09:45 PM
Williams GreggDirectorJun 06Buy1.9022,16542,18026,396,467Jun 06 08:10 PM
Williams GreggDirectorJun 05Buy1.9421,67841,94726,374,302Jun 06 08:10 PM
Williams GreggDirectorJun 04Buy1.9526,48551,51326,319,121Jun 05 09:00 PM
Williams GreggDirectorJun 01Buy1.9925,35550,33026,292,636Jun 01 08:29 PM
OKLAND STEPHEN DChief Commercial OfficerJun 01Sale1.967,43514,58723,641Jun 01 08:29 PM
Randolph Edward DavidVice President - ManufacturingJun 01Sale1.9616,02331,43722Jun 01 08:27 PM
Williams GreggDirectorMay 31Buy1.9815,60230,89226,267,281May 31 09:52 PM
Williams GreggDirectorMay 30Buy1.9812,35024,40426,251,679May 30 08:34 PM
McGuire Jonathan WillChief Executive OfficerMay 21Sale2.183,7558,18697,118May 22 09:10 PM
McGuire Jonathan WillChief Executive OfficerMay 18Option Exercise0.0011,8750100,873May 22 09:10 PM
Williams GreggDirectorMay 03Buy1.486,756,75710,000,00026,239,329May 07 09:48 PM
McGuire Jonathan WillChief Executive OfficerMar 08Option Exercise1.7311,87520,54493,214Mar 12 07:41 PM